Patent · US Active

Modulating expression of polypeptides via new gene switch expression systems

US11946054B2 · kind B2 · utility

1Cited by
17References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 22, 2020
Grant dateApr 2, 2024
Priority date
Expiry dateMay 27, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/002
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are polynucleotides encoding ligand-inducible gene switch polypeptides, and systems comprising gene switch polypeptides for modulating the expression of a heterologous gene and an interleukin in a host cell. The compositions, methods and systems described herein facilitate ligand dependent expression of polypeptides including but not limited to cytokines and antigen binding polypeptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.